Marker Therapeutics Earnings Loss from Eq. Investments (Quarterly) Analysis

Marker Therapeutics, Inc. (MRKR)

1.45 +0.08 (+5.84%) USD | NASDAQ | Mar 04, 16:00

1.45 0.00 (0.00%) After-Hours: 16:09

View Earnings Loss from Eq. Investments (Quarterly) for MRKR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Earnings Loss from Eq. Investments (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Earnings Loss from Eq. Investments (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Earnings Loss from Eq. Investments (Quarterly) Benchmarks

Start Trial

ADMA Biologics, Inc.	--
Viridian Therapeutics, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Kiniksa Pharmaceuticals International Plc	--
Neurocrine Biosciences, Inc.	--